Journal article
The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas—a randomized trial
Abstract
AIM: To assess the glucose-lowering efficacy, responsiveness, duration of action and impact on quality-of-life of hydroxychloroquine (HXCHL), when added as an antihyperglycemic agent to patients with sulfonylurea-refractory type 2 diabetes.
METHODS: One hundred and thirty-five obese patients with type 2 diabetes (mean age 57.5 years) and a glycated hemoglobin (GHb) > or = 11% despite maximum sulfonylureas were randomly allocated to the addition …
Authors
Gerstein HC; Thorpe KE; Taylor DW; Haynes RB
Journal
Diabetes Research and Clinical Practice, Vol. 55, No. 3, pp. 209–219
Publisher
Elsevier
Publication Date
March 2002
DOI
10.1016/s0168-8227(01)00325-4
ISSN
0168-8227